SHC
Sotera Health Co.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$16.40
+2.28%Year over year
Reported trailing growth
- Revenue
- +6.9%
- EBITDA
- +26.7%
- EBIT
- +28.9%
- EPS
- +210.2%
- Free cash flow
- +56.4%
- Operating cash flow
- +38.3%
Forward estimates
Based on analyst estimates
- Revenue
- +5.8%
- EBITDA
- +44.7%
- EPS
- +74.5%
Three-year CAGR
- Revenue
- +5.1%
- EBITDA
- +4.3%
- EBIT
- +16.5%
- Net income
- +23.2%
- EPS
- +22.5%
- Free cash flow
- +16.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026